Answers are grounded in this paper and cite their sources.
(3.5 μM). Hence, this PPI inhibitory activity could contribute to its antiviral activity against SARS-CoV-2 even in the absence of light by blocking its attachment to ACE2-expressing cells and making this inexpensive and widely available drug potentially useful in the prevention and treatment of COVID-19 as an oral or inhaled medication.
No takes yet. Share an insight, caveat, or question.
Bojadzic et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: